Evaxion Q1 2026 Earnings EPS Widely Misses Estimates as ClinicalStage Biotech Continues Pipeline Investment MaxCyte MXCT Q1 2026 Earnings EPS Surprises Positively on LowerThanExpected Loss Revenue Not Disclosed SKIN Q1 2026 Earnings EPS Beats Estimates Amid NarrowerThanExpected Loss ERII Q1 2026 Earnings EPS Misses Estimates as Loss Widens MGY Q1 2026 Earnings Modest EPS Beat as Operational Discipline Continues ORKA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline